Related Experiment Video
Updated: May 20, 2026

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
NlpI facilitates deposition of C4bp on Escherichia coli by blocking classical complement-mediated killing, which
Yu-ting Tseng1, Shainn-Wei Wang, Kwang Sik Kim
1Institute of Molecular Medicine, National Cheng Kung University Medical College, Tainan City, Taiwan.
Abstract:
Neonatal meningitis Escherichia coli (NMEC) is the most common Gram-negative organism that is associated with neonatal meningitis, which usually develops as a result of hematogenous spread of the bacteria. There are two key pathogenesis processes for NMEC to penetrate into the brain, the essential step for the development of E. coli meningitis: a high-level bacteremia and traversal of the blood-brain barrier (BBB). Our previous study has shown that the bacterial outer membrane protein NlpI contributes to NMEC binding to and invasion of brain microvascular endothelial cells, the major component cells of the BBB, suggesting a role for NlpI in NMEC crossing of the BBB. In this study, we showed that NlpI is involved in inducing a high level of bacteremia. In addition, NlpI contributed to the recruitment of the complement regulator C4bp to the surface of NMEC to evade serum killing, which is mediated by the classical complement pathway. NlpI may be involved in the interaction between C4bp and OmpA, which is an outer membrane protein that directly interacts with C4bp on the bacterial surface. The involvement of NlpI in two key pathogenesis processes of NMEC meningitis may make this bacterial factor a potential target for prevention and therapy of E. coli meningitis.
Insights
Neonatal meningitis Escherichia coli (NMEC) uses the NlpI protein to cause high bacteremia and evade immune responses. NlpI may be a therapeutic target for E. coli meningitis.
Area of Science:
- Microbiology
- Immunology
- Pathogenesis
Background:
- Neonatal meningitis Escherichia coli (NMEC) is a common cause of bacterial meningitis in newborns.
- NMEC pathogenesis involves high bacteremia and crossing the blood-brain barrier (BBB).
- Previous work identified the outer membrane protein NlpI's role in NMEC invasion of brain endothelial cells.
Purpose of the Study:
- To investigate the role of NlpI in NMEC pathogenesis.
- To determine NlpI's involvement in bacteremia and immune evasion.
Main Methods:
- Investigated NlpI's role in inducing bacteremia.
- Assessed NlpI's contribution to evading serum killing via the complement system.
- Explored potential interactions between NlpI, C4bp, and OmpA.
Main Results:
- NlpI was shown to be involved in inducing high-level bacteremia.
- NlpI facilitates evasion of serum killing by recruiting C4bp, a complement regulator.
- NlpI may mediate the interaction between C4bp and the outer membrane protein OmpA.
Conclusions:
- NlpI plays a significant role in two key NMEC pathogenesis processes: bacteremia and immune evasion.
- NlpI represents a potential therapeutic target for preventing and treating E. coli meningitis.
Related Concept Videos
Stringent Response in E. coli
Formation of Lipopolysaccharides
Inhibitors of Gram-positive Cell Wall Synthesis
Complement System

